Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page footer now displays Revision: v3.6.5, up from Revision: v3.6.4, indicating a deployment update.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThis change updates the revision from v3.6.3 to v3.6.4, indicating a small update to the page's documentation or release notes. It does not alter the page's primary information or user-facing features.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page text remains unchanged. No new content or deletions were detected in the study record.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page’s revision tag was updated from v3.6.1 to v3.6.3, indicating a minor update to the page’s metadata rather than a substantive change to study details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now lists Revision: v3.6.1, replacing Revision: v3.6.0.SummaryDifference0.0%

- Check60 days agoChange DetectedNew navigation sections were added on 2026-06-10, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The study site statuses now display Withdrawn in the locations list where relevant, replacing some previous labels.SummaryDifference0.3%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.